Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A1 | P19634 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7223761 | 0.74 | MAPK1 (0.36) | TSHRKMT2ALMNAHPGDSMN1; SMN2 | |
| SCHEMBL7741925 | 0.74 | SLC9A1 (0.64) | SLC9A1ALDH1A1TSHRHSD17B10KMT2A | |
| SCHEMBL27564303 | 0.73 | SLC9A1 (0.43) | SLC9A1ALDH1A1TSHRHSD17B10KMT2A | |
| SCHEMBL7746353 | 0.73 | SLC9A1 (1.00) | SLC9A1ALDH1A1TSHRHSD17B10KMT2A | |
| SCHEMBL29479875 | 0.71 | SLC9A1 (1.00) | SLC9A1ALDH1A1TSHRHSD17B10KMT2A | |
| SCHEMBL2491809 | 0.71 | SLC9A1 (1.00) | SLC9A1ALDH1A1TSHRHSD17B10KMT2A | |
| SCHEMBL439391 | 0.71 | SLC9A1 (0.64) | SLC9A1ALDH1A1TSHRHSD17B10KMT2A | |
| SCHEMBL29479871 | 0.71 | SLC9A1 (0.64) | SLC9A1ALDH1A1TSHRHSD17B10KMT2A | |
| SCHEMBL16974408 | 0.70 | KMT2A (0.70) | SLC9A1ALDH1A1TSHRHSD17B10KMT2A | |
| SCHEMBL7573640 | 0.70 | ALDH1A1 (0.57) | ALDH1A1TSHRKMT2ALMNAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6569869-B2 | In crop protection and in the protection of materials | BAYER AKTIENGESELLSCHAFT (DE) | 2003-05-27 | — | — | US | disclosed |
| US-6566383-B2 | Used for controlling undesirable microorganisms | BAYER AKTIENGESELLSCHAFT (DE) | 2003-05-20 | — | — | US | disclosed |
| US-20030032811-A1 | Microbiocides; fungicides | ASSMANN LUTZ (DE) | 2003-02-13 | — | — | US | disclosed |
| US-20020143184-A1 | Annulated azole derivatives useful as microbicidal agents | ASSMANN LUTZ (DE) | 2002-10-03 | — | — | US | disclosed |
| US-6387922-B2 | A BICYCLIC TRIAZOLE OR DIAZOLE CONTAINING SULFONYL OR PHOSPHINE OXIDE OR THIOPHOSPHORUS DERIVATIVES; USEFUL AS BACTERICIDE AND FUNGICIDE IN CROP PROTECTION | BAYER AKTIENGESELLSCHAFT (DE) | 2002-05-14 | — | — | US | disclosed |
| US-6384066-B1 | SULFONYLTRIAZOLES | BAYER AKTIENGESELLSCHAFT (DE) | 2002-05-07 | — | — | US | disclosed |
| US-20010029237-A1 | Annulated azole derivatives useful as microbicidal agents | ASSMANN LUTZ (DE) | 2001-10-11 | — | — | US | disclosed |
| EP-1117654-A1 | SULFONYLTRIAZOL DERIVATIVES AND THEIR USE FOR COMBATING MICRO-ORGANISMS | Bayer Aktiengesellschaft (DE) | 2001-07-25 | — | — | EP | disclosed |
| US-6214840-B1 | FUNGICIDES; BACTERICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2001-04-10 | — | — | US | disclosed |
| WO-2000018742-A1 | SULFONYLTRIAZOL DERIVATIVES AND THEIR USE FOR COMBATING MICRO-ORGANISMS | BAYER AKTIENGESELLSCHAFT (DE) | 2000-04-06 | — | — | WO | disclosed |
| EP-0966467-A1 | ANNULATED AZOLE DERIVATIVES USEFUL AS MICROBICIDAL AGENTS | Bayer Aktiengesellschaft (DE) | 1999-12-29 | — | — | EP | disclosed |
| WO-1998039331-A1 | ANNULATED AZOLE DERIVATIVES USEFUL AS MICROBICIDAL AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 1998-09-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010029237-A1 | Annulated azole derivatives useful as microbicidal agents | ARG1, MSR1, ARG2 | SLC9A1 561/4885ALDH1A1 304/4885TSHR 4378/4885 |
| US-20020143184-A1 | Annulated azole derivatives useful as microbicidal agents | ARG1, MSR1, ARG2 | SLC9A1 561/4885ALDH1A1 304/4885TSHR 4378/4885 |
| US-20030032811-A1 | Microbiocides; fungicides | MSR1, MPO, ARG1 | SLC9A1 1625/4885ALDH1A1 353/4885TSHR 988/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.